CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model
CRISPR/Cas9 删除人类 T 细胞中的 MIR155HG 可降低异种移植模型中急性 GVHD 的发生率和严重程度
期刊:Blood Advances
影响因子:7.4
doi:10.1182/bloodadvances.2023010570
Lotus Neidemire-Colley, Shrijan Khanal, Kara M Braunreiter, Yandi Gao, Rathan Kumar, Katiri J Snyder, Margot A Weber, Simran Surana, Olimjon Toirov, Malith Karunasiri, Molly E Duszynski, Mengna Chi, Punam Malik, Sonu Kalyan, Wing K Chan, Meisam Naeimi Kararoudi, Hannah K Choe, Ramiro Garzon, Parvath
